LEXARIA BIOSCIENCE CORP. Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount
LEXARIA BIOSCIENCE CORP. (LEXX) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount of -$280.15 thousand for the 12-month period ending 2022-08-31, per its 10-K filed 2022-11-28.
Discontinued › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpense · last filed 2022-11-28
- LEXARIA BIOSCIENCE CORP. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2022 was -$280.15K.
- LEXARIA BIOSCIENCE CORP. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2021 was -$142.90K, a 171.24% decline from fiscal 2020.
- LEXARIA BIOSCIENCE CORP. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2020 was $200.57K, a 2247.53% increase from fiscal 2019.
- LEXARIA BIOSCIENCE CORP. effective income tax rate reconciliation, nondeductible expense, amount for fiscal 2019 was $8.54K, a 213.66% increase from fiscal 2018.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount 12 month |
|---|---|
| 2022-08-31 | -$280.15K 10-K · filed 2022-11-28 |
| 2021-08-31 | -$142.90K 10-K · filed 2022-11-28 |
| 2020-08-31 | $200.57K 10-K · filed 2021-11-29 |
| 2019-08-31 | $8.54K 10-K · filed 2020-10-15 |
| 2018-08-31 | $2.72K 10-K · filed 2019-11-14 |
| 2017-08-31 | $242.63K 10-K · filed 2018-11-14 |
| 2016-08-31 | $97.61K 10-K · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |